Clinical Stage I Cutaneous Melanoma AJCC v8 Not Yet Recruiting Phase 0 Trials for Vedolizumab (DB09033)

IndicationStatusPhase
DBCOND0114027 (Clinical Stage I Cutaneous Melanoma AJCC v8)Not Yet Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03819296Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Melanoma or Genitourinary CancerDiagnostic